Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4
Clinical trial NCT01010646 · COMPLETED
Trial details
- NCT number
- NCT01010646
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-09-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.